Clinical Trial Update: JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update of a JAB-3312–based combination therapy in adults with advanced solid tumors has completed (status: completed), including non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• JAB-3312

Snippet

Sponsor: Allist Pharmaceuticals, Inc. | Conditions: Solid Tumor, NSCLC | Phase 1, Phase 2 | Status: COMPLETED